T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.60692/1w9w1-hp924
Publication URI: https://gresis.osc.int//doi/10.60692/1w9w1-hp924
Type: Other